ja
INVESTORS

IR Calendar

Q1

APRIL
MAY
Earnings announcement for full year
JUNE
General shareholders meeting

Q2

JULY
AUG
1st quarter earnings announcement
SEP

Q3

OCT
NOV
2nd quarter earnings announcement
DEC

Q4

JAN
FEB
3rd quarter earnings announcement
MARCH

2024

SCHEDULE
MAY 15, 2024
Presentation of Results for the Fiscal Year Ended March 31, 2024
FEB 14, 2024
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2024

2023

SCHEDULE
NOV 14, 2023
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2024
AUG 14, 2023
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2024
JUN 23, 2023
Ordinary General Meeting of Shareholders
MAY 15, 2023
Presentation of Results for the Fiscal Year Ended March 31, 2023
FEB 14, 2023
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2023

2022

SCHEDULE
NOV. 14, 2022
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2023
AUG. 12, 2022
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2023
JUN. 23, 2022
Ordinary General Meeting of Shareholders
MAY 16, 2022
Presentation of Results for the Fiscal Year Ended March 31, 2022
Feb. 14, 2022
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2022

2021

SCHEDULE
NOV. 12, 2021
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2022
AUG. 12, 2021
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2022
JUN. 24, 2021
Ordinary General Meeting of Shareholders
MAY 14, 2021
Presentation of Results for the Fiscal Year Ended March 31, 2021
FEB. 12, 2021
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2021

2020

SCHEDULE
NOV. 13, 2020
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2021
AUG. 13, 2020
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2021
JUN. 25, 2020
Ordinary General Meeting of Shareholders
MAY 25, 2020
Presentation of Results for the Fiscal Year Ended March 31, 2020
FEB 14, 2020
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2020

2019

SCHEDULE
NOV. 14, 2019
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2020
AUG. 14, 2019
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2020
JUN. 24, 2019
Ordinary General Meeting of Shareholders
MAY 15, 2019
Presentation of Results for the Fiscal Year Ended March 31, 2019
FEB. 14, 2019
Presentation of Third Quarter Results for the Fiscal Year Ended March 31, 2019

2018

SCHEDULE
NOV. 14, 2018
Presentation of Second Quarter Results for the Fiscal Year Ended March 31, 2019
AUG. 14, 2018
Presentation of First Quarter Results for the Fiscal Year Ended March 31, 2019

Want to learn more? Contact the Linical Investor Relations Team.

Get in Touch

Successful clinical trials start with Linical.

Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals. 

01 Request a proposal

We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.

02 Get a plan for success

We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.

03 Execute with confidence

We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.

cta-img (2)
Request a proposal from Linical, today